Track JW (Cayman) Therapeutics Ltd's current assets ($450M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest current assets for JWCTF is $450M as of June 2026. That compares with $750M in the prior-year period — down 39.6% year over year. Investors often review this figure alongside JW (Cayman) Therapeutics Ltd's historical trend and sector peers before judging valuation or financial health.
Over the past year, JWCTF's current assets moved from $750M to $450M — a 39.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in JW (Cayman) Therapeutics Ltd's operating scale or balance-sheet position.
A current assets figure of $450M for JWCTF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting JWCTF's current assets ($450M), review year-over-year change from $750M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack JW (Cayman) Therapeutics Ltd's current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.